Insider Trading activities at Cytokinetics Inc (CYTK) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytokinetics Inc (CYTK) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytokinetics Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1061983.

Total stock buying since 2015: $3,409,639.
Total stock sales since 2015: $141,802,280.
Total stock option exercises since 2015: $22,061,108.


 1   2   3   4 
20 insiders reported insider trading activities at Cytokinetics Inc (CYTK):
Insider trading activities of Bhanji Muna
Insider trading activities of Blum Robert I
Insider trading activities of Lampert Mark N
Insider trading activities of Harrington Robert Arthur
Insider trading activities of Wolff Andrew A
Insider trading activities of Costa Santo J
Insider trading activities of Callos Andrew
Insider trading activities of Gage L Patrick
Insider trading activities of Schlossberg Mark A
Insider trading activities of Cragg David
Insider trading activities of Morgan Bradley Paul
Insider trading activities of Mcdowell Caryn Gordon
Insider trading activities of Kaye Edward M. Md
Insider trading activities of Malik Fady Ibraham
Insider trading activities of Wong Robert
Insider trading activities of Parshall B Lynne
Insider trading activities of Wierenga Wendall
Insider trading activities of Smith Sandford D
Insider trading activities of Henderson John T
Insider trading activities of Jaw Ching

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Cytokinetics Inc (CYTK).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 301,628 $12,455,598 87,000 $1,012,460
2024 0 $0 566,913 $33,770,931 441,385 $3,574,553
2023 0 $0 336,003 $12,584,418 302,540 $2,503,702
2022 0 $0 602,547 $26,510,660 622,168 $5,834,212
2021 0 $0 481,309 $16,423,971 491,287 $4,201,854
2020 0 $0 1,947,945 $35,408,116 442,810 $3,361,709
2019 348,072 $3,280,519 64,000 $656,817 0 $0
2018 0 $0 50,709 $406,852 2,709 $17,798
2017 0 $0 229,802 $3,344,442 182,703 $1,417,008
2016 0 $0 5,633 $69,632 0 $0
2015 21,000 $129,120 21,875 $170,843 21,875 $137,812


Table 3. Detailed insider trading at Cytokinetics Inc (CYTK) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2021-12-09 Malik Fady Ibraham (EVP Research & Development) Sale 29,166 36.49 1,064,296
2021-12-09 Malik Fady Ibraham (EVP Research & Development) Option Ex 29,166 6.30 183,745
2021-11-19 Smith Sandford D (Director) Sale 29,032 41.20 1,196,263
2021-11-19 Smith Sandford D (Director) Option Ex 29,032 12.03 349,342
2021-11-12 Blum Robert I (President & CEO) Sale 4,143 39.63 164,170
2021-11-12 Blum Robert I (President & CEO) Option Ex 4,143 6.00 24,858
2021-11-11 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 39.56 79,120
2021-11-09 Cragg David (Chief HR & Admin Officer) Sale 45,000 41.76 1,879,200
2021-11-09 Cragg David (Chief HR & Admin Officer) Option Ex 45,000 9.65 434,250
2021-11-08 Gage L Patrick (Director) Sale 26,468 41.33 1,094,028
2021-11-08 Gage L Patrick (Director) Option Ex 26,468 4.74 125,458
2021-11-05 Henderson John T (Director) Sale 8,503 40.00 340,120
2021-11-05 Henderson John T (Director) Option Ex 8,503 5.88 49,997
2021-11-01 Cragg David (Chief HR & Admin Officer) Sale 25,000 34.89 872,250
2021-11-01 Cragg David (Chief HR & Admin Officer) Option Ex 25,000 6.00 150,000
2021-10-29 Blum Robert I (President & CEO) Sale 5,000 35.80 178,995
2021-10-29 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-10-19 Jaw Ching (SVP Finance & CFO) Sale 35,687 35.73 1,275,203
2021-10-19 Schlossberg Mark A (SVP - Legal & General Counsel) Sale 19,979 35.74 713,969
2021-10-19 Schlossberg Mark A (SVP - Legal & General Counsel) Option Ex 19,979 7.03 140,452
2021-10-19 Parshall B Lynne (Director) Sale 10,332 35.73 369,203
2021-10-19 Parshall B Lynne (Director) Option Ex 10,332 6.72 69,431
2021-10-14 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 37.73 75,452
2021-10-14 Blum Robert I (President & CEO) Sale 5,000 37.74 188,715
2021-10-14 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-10-01 Cragg David (Chief HR & Admin Officer) Sale 7,569 35.14 265,989
2021-09-30 Blum Robert I (President & CEO) Sale 5,000 34.01 170,065
2021-09-30 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-09-15 Blum Robert I (President & CEO) Sale 5,000 32.66 163,314
2021-09-15 Blum Robert I (President & CEO) Option Ex 5,000 6.15 30,750
2021-09-09 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 31.43 62,860
2021-09-02 Blum Robert I (President & CEO) Sale 5,000 33.12 165,575
2021-09-02 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-09-01 Cragg David (Chief HR & Admin Officer) Sale 7,850 32.78 257,315
2021-08-18 Blum Robert I (President & CEO) Sale 5,000 31.14 155,710
2021-08-18 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-08-12 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 32.60 65,200
2021-08-05 Blum Robert I (President & CEO) Sale 5,000 29.12 145,605
2021-08-05 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-08-02 Cragg David (Chief HR & Admin Officer) Sale 2,616 29.67 77,616
2021-07-22 Blum Robert I (President & CEO) Sale 5,000 29.82 149,120
2021-07-22 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-07-19 Smith Sandford D (Director) Sale 11,965 29.00 346,985
2021-07-19 Smith Sandford D (Director) Option Ex 11,965 10.68 127,786
2021-07-08 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 19.48 38,952
2021-07-06 Blum Robert I (President & CEO) Sale 5,000 20.13 100,670
2021-07-06 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-06-10 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 21.48 42,952
2021-06-03 Blum Robert I (President & CEO) Sale 5,000 20.61 103,045
2021-06-03 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-05-13 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 24.42 48,840
2021-05-07 Blum Robert I (President & CEO) Sale 5,000 23.21 116,039
2021-05-07 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-04-30 Blum Robert I (President & CEO) Sale 5,000 25.87 129,360
2021-04-30 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-04-27 Smith Sandford D (Director) Sale 9,739 27.75 270,257
2021-04-27 Smith Sandford D (Director) Option Ex 9,739 10.62 103,379
2021-04-23 Smith Sandford D (Director) Sale 5,000 26.50 132,500
2021-04-23 Smith Sandford D (Director) Option Ex 5,000 9.45 47,250
2021-04-12 Blum Robert I (President & CEO) Sale 5,000 23.56 117,815
2021-04-12 Blum Robert I (President & CEO) Option Ex 5,000 6.30 31,500
2021-04-08 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 23.39 46,772
2021-04-01 Henderson John T (Director) Sale 3,333 23.54 78,458
2021-04-01 Henderson John T (Director) Option Ex 3,333 8.64 28,797
2021-03-22 Blum Robert I (President & CEO) Sale 5,000 25.20 125,975
2021-03-22 Blum Robert I (President & CEO) Option Ex 5,000 6.15 30,750
2021-03-19 Gage L Patrick (Director) Sale 10,000 24.45 244,470
2021-03-19 Gage L Patrick (Director) Option Ex 10,000 5.88 58,800
2021-03-12 Gage L Patrick (Director) Sale 10,339 21.22 219,372
2021-03-12 Gage L Patrick (Director) Option Ex 10,339 7.26 75,061
2021-03-11 Malik Fady Ibraham (EVP Research & Development) Sale 2,000 19.90 39,798
2021-03-08 Blum Robert I (President & CEO) Sale 5,000 19.49 97,470
2021-03-08 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-02-26 Blum Robert I (President & CEO) Sale 5,000 19.33 96,649
2021-02-26 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-02-18 Blum Robert I (President & CEO) Option Ex 83,332 9.42 784,987
2021-02-11 Malik Fady Ibraham (EVP Research & Development) Sale 1,632 23.34 38,097
2021-02-10 Blum Robert I (President & CEO) Sale 5,000 23.88 119,385
2021-02-10 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-01-29 Blum Robert I (President & CEO) Sale 5,000 20.34 101,700
2021-01-29 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-01-20 Blum Robert I (President & CEO) Sale 5,000 20.41 102,045
2021-01-20 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2021-01-14 Malik Fady Ibraham (EVP Research & Development) Sale 12,500 19.25 240,625
2021-01-14 Malik Fady Ibraham (EVP Research & Development) Option Ex 12,500 9.42 117,750
2021-01-04 Blum Robert I (President & CEO) Sale 5,000 20.23 101,135
2021-01-04 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-12-31 Henderson John T (Director) Sale 858 20.31 17,425
2020-12-31 Henderson John T (Director) Option Ex 858 12.96 11,119
2020-12-16 Blum Robert I (President & CEO) Sale 5,000 20.51 102,550
2020-12-16 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-12-15 Cragg David (SVP Human Resources) Option Ex 16,666 9.42 156,993
2020-12-15 Gage L Patrick (Director) Sale 7,716 21.00 162,036
2020-12-15 Gage L Patrick (Director) Option Ex 7,716 12.96 99,999
2020-12-10 Malik Fady Ibraham (EVP Research & Development) Sale 1,052 20.13 21,176
2020-12-09 Lampert Mark N Sale 430,954 18.00 7,757,172
2020-12-04 Blum Robert I (President & CEO) Sale 5,000 17.36 86,800
2020-12-04 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-11-23 Blum Robert I (President & CEO) Sale 5,000 15.73 78,645
2020-11-23 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-11-12 Malik Fady Ibraham (EVP Research & Development) Sale 1,231 17.15 21,111
2020-11-10 Blum Robert I (President & CEO) Sale 5,000 16.50 82,490
2020-11-10 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-10-29 Blum Robert I (President & CEO) Sale 5,000 15.15 75,775
2020-10-29 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-10-13 Blum Robert I (President & CEO) Sale 5,000 15.94 79,685
2020-10-13 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-10-08 Malik Fady Ibraham (EVP Research & Development) Sale 1,258 17.45 21,952
2020-10-05 Jaw Ching (SVP Finance & CFO) Sale 27,500 30.00 825,000
2020-10-05 Jaw Ching (SVP Finance & CFO) Option Ex 27,500 9.01 247,857
2020-10-05 Kaye Edward M. Md (Director) Sale 20,000 30.00 600,000
2020-10-05 Kaye Edward M. Md (Director) Option Ex 20,000 7.61 152,200
2020-10-05 Smith Sandford D (Director) Sale 5,936 30.00 178,080
2020-10-05 Smith Sandford D (Director) Option Ex 5,936 7.37 43,748
2020-10-05 Henderson John T (Director) Sale 3,000 29.00 87,000
2020-10-05 Henderson John T (Director) Option Ex 3,000 12.96 38,880
2020-10-05 Parshall B Lynne (Director) Sale 50,311 30.00 1,509,330
2020-10-05 Parshall B Lynne (Director) Option Ex 50,311 7.80 392,325
2020-10-05 Costa Santo J (Director) Sale 15,000 30.00 450,000
2020-10-05 Costa Santo J (Director) Option Ex 15,000 9.45 141,750
2020-10-02 Blum Robert I (President & CEO) Sale 5,000 22.53 112,645
2020-10-02 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-09-21 Blum Robert I (President & CEO) Sale 5,000 20.97 104,835
2020-09-21 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-09-11 Blum Robert I (President & CEO) Sale 5,000 22.95 114,735
2020-09-11 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-09-10 Malik Fady Ibraham (EVP Research & Development) Sale 995 22.85 22,735
2020-09-04 Blum Robert I (President & CEO) Sale 5,000 22.37 111,855
2020-09-04 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-08-21 Jaw Ching (SVP Finance & CFO) Sale 25,000 25.00 625,000
2020-08-21 Jaw Ching (SVP Finance & CFO) Option Ex 25,000 7.47 186,750
2020-08-21 Schlossberg Mark A (SVP - Legal & General Counsel) Sale 10,000 25.00 250,000
2020-08-21 Schlossberg Mark A (SVP - Legal & General Counsel) Option Ex 10,000 7.03 70,300
2020-08-18 Blum Robert I (President & CEO) Sale 5,000 23.48 117,420
2020-08-18 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-08-13 Malik Fady Ibraham (EVP Research & Development) Sale 599 21.85 13,088
2020-08-05 Blum Robert I (President & CEO) Sale 5,000 22.12 110,620
2020-08-05 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-07-29 Schlossberg Mark A (SVP - Legal & General Counsel) Sale 10,000 23.07 230,730
2020-07-29 Schlossberg Mark A (SVP - Legal & General Counsel) Option Ex 10,000 7.03 70,300
2020-07-28 Blum Robert I (President & CEO) Sale 5,000 23.77 118,829
2020-07-28 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-07-16 Blum Robert I (President & CEO) Sale 5,000 27.36 136,805
2020-07-16 Blum Robert I (President & CEO) Option Ex 5,000 6.00 30,000
2020-07-15 Smith Sandford D (Director) Sale 6,667 29.00 193,343
2020-07-15 Smith Sandford D (Director) Option Ex 6,667 6.21 41,402
2020-07-10 Smith Sandford D (Director) Sale 6,667 28.00 186,676
2020-07-10 Smith Sandford D (Director) Option Ex 6,667 6.21 41,402
2020-07-09 Malik Fady Ibraham (EVP Research & Development) Sale 1,587 26.96 42,785
2020-07-08 Smith Sandford D (Director) Sale 1,434 27.00 38,718
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of CYTK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytokinetics Inc (symbol CYTK, CIK number 1061983) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.